Detalhe da pesquisa
1.
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Mol Cancer
; 23(1): 78, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643157
2.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750115
3.
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Invest New Drugs
; 42(1): 145-159, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324085
4.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Lancet Oncol
; 24(9): 1002-1017, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657460
5.
Small cell lung cancer: Novel treatments beyond immunotherapy.
Semin Cancer Biol
; 86(Pt 2): 376-385, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568295
6.
Baseline extracellular vesicle TGF-ß is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
Cancer
; 129(4): 521-530, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484171
7.
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.
Cancer Control
; 30: 10732748231175256, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148308
8.
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Br J Cancer
; 126(3): 514-520, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480094
9.
Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology.
J Cancer Educ
; 37(1): 231-236, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655420
10.
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.
Lancet Oncol
; 22(11): e488-e500, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735818
11.
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
Oncologist
; 26(12): 1035-1043, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498780
12.
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
J Neurooncol
; 154(3): 353-364, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498213
13.
A New Generation of Vaccines in the Age of Immunotherapy.
Curr Oncol Rep
; 23(12): 137, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735649
14.
Immunotherapy in Lung Cancer: Are the Promises of Long-Term Benefit Finally Met?
Adv Exp Med Biol
; 1342: 113-142, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972964
15.
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 261-270, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838015
16.
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function.
J Cell Physiol
; 235(11): 8085-8097, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960422
17.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Br J Clin Pharmacol
; 86(9): 1807-1818, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227355
18.
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1).
Curr Oncol Rep
; 22(5): 48, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296961
19.
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
Drug Resist Updat
; 46: 100644, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585395
20.
Immunotherapy in Lung Cancer: From a Minor God to the Olympus.
Adv Exp Med Biol
; 1244: 69-92, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301011